Education
About Us
Working with TipRanks
Follow Us
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
Total Valuation
Belite Bio, Inc. ADR has a market cap or net worth of $5.20B. The enterprise value is $1.73B.
Market Cap$5.20B
Enterprise Value$1.73B
Share Statistics
Belite Bio, Inc. ADR has 37,514,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,514,630
Owned by Insiders―
Owned by Institutions5.07%
Financial Efficiency
Belite Bio, Inc. ADR’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -27.33%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.24
Return on Invested Capital (ROIC)-27.33%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee0.00
Profits Per Employee-1.45M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Belite Bio, Inc. ADR is ―. Belite Bio, Inc. ADR’s PEG ratio is 63.44.
PE Ratio―
PS Ratio0.00
PB Ratio13.21
Price to Fair Value13.21
Price to FCF-65.58
Price to Operating Cash Flow0.00
PEG Ratio63.44
Income Statement
In the last 12 months, Belite Bio, Inc. ADR had revenue of 0.00 and earned -36.14M in profits. Earnings per share was -1.18.
Revenue0.00
Gross Profit0.00
Operating Income-40.00M
Pretax Income-36.14M
Net Income-36.14M
EBITDA-35.67M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Belite Bio, Inc. ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change144.93%
50-Day Moving Average115.70
200-Day Moving Average77.05
Relative Strength Index (RSI)66.81
Average Volume (3m)64.23K
Important Dates
Belite Bio, Inc. ADR upcoming earnings date is Mar 27, 2026, Before Open (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateMar 27, 2026
Ex-Dividend Date―
Financial Position
Belite Bio, Inc. ADR as a current ratio of 24.31, with Debt / Equity ratio of 0.00%
Current Ratio24.31
Quick Ratio24.31
Debt to Market Cap0.00
Net Debt to EBITDA0.87
Interest Coverage Ratio-2.00K
Taxes
In the past 12 months, Belite Bio, Inc. ADR has paid 6.00K in taxes.
Income Tax6.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Belite Bio, Inc. ADR EV to EBITDA ratio is -53.15, with an EV/FCF ratio of -64.52.
EV to Sales0.00
EV to EBITDA-53.15
EV to Free Cash Flow-64.52
EV to Operating Cash Flow-64.85
Balance Sheet
Belite Bio, Inc. ADR has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share$4.64
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Belite Bio, Inc. ADR is $167.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$167.50
Price Target Upside8.62% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast-73.27%